Today is the day for this years Research Summit! We can't wait to welcome you for a day filled with insights and conversations on the present and future of genomic research and medicine. There's a great selection of speakers, panel discussions, abstract presentations and networking sessions being held throughout the day. Plan your day with the agenda, available via this link: https://ow.ly/P6tP50SxCrX#GERS2024 🧬
𝐎𝐧𝐥𝐲 𝟕 𝐝𝐚𝐲𝐬 𝐥𝐞𝐟𝐭 𝐮𝐧𝐭𝐢𝐥 𝐍𝐞𝐱𝐭𝐆𝐞𝐧 𝐎𝐦𝐢𝐜𝐬 𝐔𝐒 𝟐𝟎𝟐𝟒! 🎉
In just one week, we'll gather in Boston for the pinnacle event in omics research, leveraging multi-omic data to unlock transformative insights into cellular biology, disease and drug discovery. What breakthroughs are you most eager to explore? Let us know in the comments 👇
Time is running out to reserve your place! You can register here: https://hubs.la/Q02pfxQC0#OGOmics#NextGenOmicsUS24
Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?
This invited review follows the oral presentation “To Sequence or Not to Sequence, That Is Not the Question; But ‘When, Who, Which and What For?’ Is” given during the State of the Art session “Translational Genomics in Thrombosis: From OMICs to Clinics” of the International Society on Thrombosis and Haemostasis 2023 Congress.
https://lnkd.in/g2NDU_Nr
David Alexandre Trégouët | MORANGE PIERRE-EMMANUEL
Excited to share our new research in the Med-Gemini family. Our research pushes the boundaries of multimodal capabilities across clinical domains. Our Med-Gemini models excel in medical visual Q&A, report generation (CXR, CT scans), disease risk prediction from genomics, & classification across a range of benchmarks.
arxiv.org/pdf/2405.03162
A new research paper by our incredible teams at Google Research and Google DeepMind shows the strong performance of Med-Gemini across a variety of multimodal tasks, including 2D and 3D imaging in radiology, histopathology, ophthalmology, and dermatology, and genomics. Med-Gemini ranked best in class on chest X-ray and CT scan report generation, and is able to perform genomics-based disease prediction and mortality risk more accurately than a standard linear polygenic risk score (PRS) based approach. This work couldn't have been possible without close collaboration with our partners, including a panel of specialists who assessed and rated our models as part of this research.
These promising results showcase the potential of LLMs to transform medicine as we know it.
https://lnkd.in/dHx8_DYh
Excited to share our new research in the Med-Gemini family. Our research pushes the boundaries of multimodal capabilities across clinical domains. Our Med-Gemini models excel in medical visual Q&A, report generation (CXR, CT scans), disease risk prediction from genomics, & classification across a range of benchmarks.
arxiv.org/pdf/2405.03162
🚀 Unlocking the Future of Genomic Analysis with the Stratys™ System by Bionano! 🧬
Discover the cutting-edge capabilities of the Stratys™ System, revolutionizing genomic analysis with unparalleled structural variant detection at scale.
🌐 Explore how the Stratys™ System empowers researchers and clinicians to uncover complex genomic variations, driving breakthroughs in disease research, precision medicine, and beyond.
Ready to elevate your genomic analysis? Learn more about the transformative potential of the Stratys™ System today on :
#Genetrics#Bionano#StratysSystem#GenomicAnalysis#PrecisionMedicine#HealthcareInnovation 🚀
Did you know that using 10x Genomics#scRNA-seq for #drugtarget identification could triple your target's chances of progressing to a phase III trial? This cutting-edge approach enhances precision in identifying viable targets, increasing the success rate of #clinical trials.
Learn more in this preprint: https://zurl.co/p3oR
Exciting to see more FFPE samples easily processed through the automation of the S200+! Are you ready to get out of the safety cabinet and automate the whole process to single cells and nuclei right on the bench-top? #FFPE#automation
Searching for ways to enrich for rare populations in FFPE tissues for your single cell assay?
Your search is over. Join us at the 10x Genomics Single Cell and Spatial User Day where Dr. Caleb Lareau , (MSKCC), will present his recent publication, “Transcript-specific enrichment enables profiling rare cell states via scRNA-seq.” Dr. Lareau used the Singulator™ Platform to develop a novel approach to enrich or deplete cell populations from FFPE samples.
June 5, 2024, 10:00 AM–6:00 PM ET
Location:
The Franklin Institute
222 N 20th Street
Philadelphia, PA 19103
Registration:
https://hubs.la/Q02y-R2m0
The link to the publication:
https://hubs.la/Q02y-SZ30#singlecell#FFPE
Assistant Professor of Neurology at University of California, San Francisco
Working with PacBio and Gladstone Genomics Core, we optimized single molecule sequencing for measuring the C9 repeat expansion (called No Amp). This was the brainchild of Yu-Chih Tsai. Congrats to Katie Brown on getting this protocol out to all of you! https://lnkd.in/g4NTbJEU
Version 2.0 called PureTarget which can measure 20 repeat expansions is now available from PacBio. https://lnkd.in/gM5wstxf
🎙️ Unlocking the Future of Genomic Data 🎙️
In this insightful discussion with Max Gilbert, Michael Becich, CEO of Cache DNA, explores the immense potential of clinical research samples. The true value of these samples lies not just in the immediate sequencing, but in the raw data that can be revisited for groundbreaking discoveries. This approach ensures that every sample contributes to long-term advancements in genomics and personalized medicine. 🧬
Curious to see how Cache DNA can elevate your research? We’re offering demo kits to give you a firsthand look at how our platform can help manage your precious genomic samples for maximum impact. Reach out to learn more and get your kit today: https://lnkd.in/gVzSJZxK#CacheDNA#Genomics#DataScience#ResearchInnovation#PersonalizedMedicine#DemoKit#LifeSciences
Lecturer in Clinical Genetics at University of Derby
3moGreat opportunity! For me to present my work today